We studied the metabolic consequences of ASS1 epigenetic silencing in mesothelioma and bladder cancer cell lines, identifying reduced thymidine levels and increased levels of thymine and glutamine upon ADI-PEG20 treatment [12]. This evidence concerns the gene ASS1 and mesothelioma.